20-F/A

AMENDMENT NO. 2

Company: XTL BIOPHARMACEUTICALS LTD
Filed: June 11, 2012
Period of Report: December 31, 2011
Accession Number: 0001144204-12-034143

View Document ↗ View on SEC.gov ↗